查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1847979

医用复合材料市场：依最终用途产业、树脂类型、纤维类型、製造流程、外形规格及产品类型划分－2025-2032年全球预测

Medical Composites Market by End Use Industry, Resin Type, Fiber Type, Manufacturing Process, Form Factor, Product Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，医用复合材料市场规模将达到 57.3 亿美元，复合年增长率为 16.99%。

主要市场统计数据
基准年 2024 16.3亿美元
预计年份：2025年 19.1亿美元
预测年份：2032年 57.3亿美元
复合年增长率 (%) 16.99%

本书清晰权威地介绍了复合材料如何再形成整个医疗保健环境中的医疗设备设计、製造和临床性能。

先进复合材料兼具优异的机械性能、轻量化设计以及与临床工作流程的兼容性，已成为下一代医疗设备和植入的关键推动因素。过去十年间，由于聚合物化学、纤维技术和製程可重复性的进步，复合材料已从小众应用领域发展成为主流产品架构，这些进步共同解决了长期存在的临床和製造难题。生物相容性热塑性塑胶、客製化纤维增强材料和精密製造技术的融合，在满足临床医生对可消毒、透射X射线和抗疲劳组件的需求的同时，也为器械工程师提供了更大的设计渗透性。

临床应用的进一步推动因素是手术方式向微创手术的转变，以及植入设计对高强度重量比和模组化的要求。同时，医疗采购和医院技术评估机构也越来越重视产品的生命週期性能和可维护性，凸显了耐用复合复合材料解决方案的重要性。这种趋势迫使医疗设备製造商、材料供应商和契约製造在材料选择、製程检验和监管文件方面密切合作。因此，医用复合材料不再只是材料的选择，而是一个系统层面的决策，它会影响生产规模、供应链架构以及新设备进入高度监管市场的速度。

对正在加速医疗复合材料创新并改变竞争动态的重大技术、监管和永续性变革进行精闢概述

在技​​术进步、法规演变和跨领域知识转移的推动下，医用复合材料领域正经历着一场变革。树脂化学和纤维工程的创新使得刚度、韧性和灭菌兼容性等以往难以实现的组合成为可能，而增材製造和自动化系统则降低了人工操作的差异性，并实现了患者个体化的形态学设计。同时，对永续性和循环性的日益重视推动了可回收热塑性塑胶和新型树脂化学技术的研发，这些技术在不牺牲生物相容性的前提下，降低了对环境的影响。这些技术和环境趋势相辅相成，为供应商和原始设备製造商（OEM）创造了新的竞争优势。

为了适应复杂的多材料医疗器械，法律规范也不断发展演变。监管机构日益重视材料可追溯性、灭菌验证和长期性能数据，从而影响了资格确认时间表和文件要求。此外，航太和汽车领域，尤其是在品质系统、无损检测和供应链审核方面的经验教训，正被应用于医疗领域，加速了製造和认证实践的成熟。这些转变共同重塑了产品蓝图的製定方式、伙伴关係的优先顺序以及如何部署资金以扩大生产规模，同时确保合规性和患者安全。

本文对2025年关税如何改变医疗复合材料价值链的筹资策略、供应商关係和生产重点进行了务实的分析。

美国2025年实施的新关税对医疗复合材料生态系统产生了广泛而累积的影响，促使製造商和供应商进行供应链重组并采取策略性应对措施。面对某些原材料和成品组件进口关税的提高，许多公司重新评估了筹资策略，以减少对单一国家的依赖。这加速了企业对供应商多元化、区域供应基地以及包含紧急条款和成本分摊机制的长期采购合约的兴趣。

在产品层面，关税提升了国产树脂和纤维的相对吸引力，促使企业投资于本地的混合、纤维加工和预浸料生产。医疗设备公司的采购团队也更积极主动地对替代材料进行资质认证，并协商缩短前置作业时间，以确保生产的连续性。同时，契约製造製造商和加工商正寻求透过製程优化、提高产量比率和选择性地调整价格来缓解利润压力，并积极开展设计评审，以在临床适用的情况下寻找材料替代的机会。

政策主导的成本压力也推动了近岸外包的讨论，相关人员正在权衡人事费用、监管便利性和供应可靠性之间的利弊。值得注意的是，关税正在促进树脂生产商和医疗设备製造商 (OEM) 之间的上游伙伴关係，加速联合开发可减少对受关税影响的原材料依赖的树脂等级。这种因应措施正在将资本配置转向灵活性和韧性，即便企业力求维持产品效能和合规性。

全面的市场细分洞察，揭示最终用途、树脂化学、纤维等级、製造流程、外形规格和产品类型如何相互作用，从而塑造策略重点。

细分市场层面的动态凸显了不同终端用途、材料类型、纤维结构、製造流程、外形规格和产品类型所带来的机会和挑战的异质性。就终端用途产业细分而言，应用领域涵盖航太与国防（机身、内装和机翼部件）；汽车（车身面板、底盘和内装部件）；医疗保健（医疗设备、整形外科植入和矫正器具）；船舶（甲板结构和船体）；运动休閒（自行车、高尔夫球桿和球拍）；以及风力发电（叶片、轮圈和风扇）。每种应用对性能、灭菌和使用寿命的要求各不相同，这会影响材料的选择和认证管道。

对树脂类型进行细分有助于更清晰地了解其发展轨迹。在聚醚醚酮（PEEK）中，碳纤维增强型和非增强型之间的区别会影响其刚度和渗透性；聚丙烯（PP）的共聚物和均聚物等级则在成本和延展性之间取得平衡；聚苯乙烯（PPS）中的玻璃纤维增强型产品则具有耐温性和耐化学性。环氧树脂体系，例如双酚A、脂环族和酚醛树脂，在韧性和热稳定性方面各有优劣；聚酯体系，例如二氯苯酚（DCPD）、间苯二甲酸乙二醇酯和邻苯二甲酸乙二醇酯，满足对成本要求较高的结构需求；而乙烯基酯体系，例如阿特拉斯、德拉烷和维奥瓦，则具有耐腐蚀性。

酰胺纤维依其抗衝击性和抗切割性分为间位芳香聚酰胺和对位芳香聚酰胺。碳纤维分为聚丙烯腈（PAN）基、沥青基和人造丝基，具有不同的刚性和重量特性。玻璃纤维，例如C玻璃、E玻璃和S玻璃，以具有竞争力的成本提供可扩展的强度。细分製造工艺，包括高压釜成型、压缩缠绕成型、手工积层成型、拉挤成型和树脂转注成形，对零件形状、週期时间和品质保证通讯协定有着不同的限制，从而影响单位成本和认证进度。外形规格包括管道、管材、型材、织物和不织布布、棒材和条材以及板材，每种形状都会影响下游加工和后处理过程。产品类型涵盖导电和标准块状模塑胶；缠绕缠绕成型产品，包括管道、管材和压力容器；碳纤维和玻璃纤维预浸料；拉挤成型型材，例如角钢、槽钢和工字钢；以及优质和标准片状成型塑料。

将这些环节组合起来，便形成了一个包含技术需求、供应风险和机会的矩阵。从一个环节过渡到另一个环节通常需要调整供应商合格、检验通讯协定和生产控制。例如，从手工积层过渡到自动化缠绕成型，需要投资于模具、无损检测和製程监控。同样，从热固性预浸料过渡到热塑性解决方案可以带来回收的优势，但需要重新调整模具并进行改造以符合灭菌要求。了解这些相互依存关係，有助于产品团队在效能、成本和上市时间之间做出权衡。

战略区域分析概述了美洲、欧洲、中东和非洲以及亚太地区将如何影响医用复合材料的采购、监管和製造选择。

区域动态在塑造采购决策、监管管道和创新重点方面发挥着至关重要的作用。在美洲，成熟的医疗设备丛集、毗邻主要医疗保健采购商以及注重实证的法规环境，共同为高性能复合材料的应用创造了沃土，这些应用需要快速的临床应用以及与供应商的密切合作。本土製造能力和工程师人才储备为近岸外包策略提供了支援。

欧洲、中东和非洲地区（EMEA）的特征是产业基础多元化，监管环境强调医疗器材的生命週期监控和可追溯性。欧盟的医疗设备法律规范和区域标准会影响材料合格和上市后义务，促使製造商投资更全面的测试和文件记录。此外，欧洲部分地区拥有强大的航太和风力发电丛集，促进了先进复合复合材料丛集技术的交流。

亚太地区在纤维和树脂製造以及复合材料加工领域投入巨资，在多个地区具备规模化和成本竞争力强的製造能力。该地区部分地区医疗保健需求的快速增长推动了先进设备的在地化应用，而政府对製造业和技术发展的奖励也加速了产能扩张。然而，由于监管成熟度和供应链透明度的差异，采购方在从该地区多个国家采购时必须采取严格的资格认证流程。这些区域性特征会影响供应商选择、库存策略以及在地化能力投资等方面的策略决策。

基于证据的评估，分析树脂生产商、纤维供应商、加工商、原始设备製造商和服务供应商如何透过其技术、整合和监管能力实现差异化。

医疗复合材料价值链中的主要企业透过技术优势、供应链整合和监管专业知识的结合来脱颖而出。专注于开发特殊树脂的公司正在投资研发兼俱生物相容性、耐灭菌性和加工性能的树脂等级，而纤维製造商则在扩大碳纤维和玻璃纤维的产能，以满足严格的医疗性能要求。复合材料加工商和契约製造製造商正在扩展自动化和测试能力，以降低差异性并提高高混合医疗专案的产量。

医疗设备製造商 (OEM) 越来越多地与材料供应商建立策略联盟，以加快产品特定认证流程并降低长前置作业时间投入的风险。这一趋势，加上对内部法规和材料科学团队投入的增加，使得从材料选择到临床验证的过渡更加迅速。包括实验室和灭菌专家在内的服务供应商正在扩展其服务范围，涵盖加速老化测试、生物相容性测试以及复合材料结构的全面无损检测。

此外，成功的企业正优先考虑永续性倡议，例如生命週期评估和可回收材料系统，因为他们意识到医疗保健采购负责人越来越重视环境影响。併购和共同开发契约正被用来获取专业技术、确保本地供应并获取监管文件。此外，企业领导者正在投资人才培养，以填补复合材料製造和品质保证的技能缺口。

为产业领导者提供切实可行的建议，以增强供应链韧性、加快材料认证速度并实现製造营运现代化。

产业领导者应协调并采取一系列战术性和策略行动，在增强韧性的同时保持创新步伐。首先，应优先考虑供应链多元化，对不同地区的多个供应商进行资格认证，并建立关键树脂和纤维的紧急库存缓衝。同时，应加快材料合格计划，检验能够满足临床和灭菌要求的替代树脂和纤维组合，从而减少对受关税影响的原材料的依赖。

第二，我们正投资于生产现代化，专注于自动化、线上检测和数位化追溯，以降低产品个体差异并提高产量比率。这些投资正在缩短资格确认週期，并提高各生产基地之间的可重复性。第三，我们在产品开发的早期阶段就融入了监管策略，透过提交前咨询与监管机构沟通，并维护完善的材料和工艺文檔，以简化核准流程。第四，我们正在製定循环经济策略，包括使用可回收热塑性塑胶、采用可拆卸设计，并在临床适用的情况下重复使用经验证的、可灭菌的材料，从而使产品系列与采购和永续性优先事项保持一致。

第五，我们将与材料供应商、製造外包和临床合作伙伴合作，共用风险，加速临床应用进程。最后，我们将投资于员工技能和变革管理，使团队能够操作新的製造技术并确保合规性，从而将技术投资转化为可靠的生产和市场准入。

一份透明的调查方法说明，解释了用于得出策略洞察的综合性一手和二手研究方法、供应链映射和检验步骤。

本概述的研究采用了混合方法，整合了主要相关人员参与、技术文献综述和有针对性的供应链分析。主要资讯来源包括对材料科学家、製造工程师、采购负责人、法规事务专家和临床最终用户进行结构化访谈，以了解营运限制、性能优先事项和合格困难。此外，还查阅了同行评审的工程文献、监管指导文件、专利申请以及概述医疗应用材料和工艺预期标准的文献。

透过供应链映射，识别了原材料转化、预浸料和复合材料製造以及最终组装的关键节点，从而分析了前置作业时间脆弱性和集中风险。技术评估评估了热塑性和热固性树脂体系、纤维类型以及自动化製造平台的成熟度，同时透过应用案例重点介绍了成功的认证和生产规模化途径。为确保研究成果的实际应用性，我们透过专家研讨会和跨职能评审反覆检验了所获得的见解。调查方法的局限性包括各组织独特的合格标准以及不断变化的政策环境。

简洁地总结了材料创新、製造流程现代化和策略供应链决策将如何决定医用复合材料的成功。

医用复合材料正处于曲折点，材料创新、製造流程的演进和政策动态既带来了风险，也带来了机会。该领域能够提供更轻、更强、更具临床意义的解决方案，从而拓展了医疗器材设计的可能性；同时，监管和采购方面的要求也对可追溯性和性能文件提出了更高的要求。贸易政策的转变和区域市场的动态变化正在加速供应链的策略调整，促使企业加强对多元化、近岸外包和供应商伙伴关係的投资。

为了因应这种环境，企业必须采取整合策略，将材料科学、製程工程、监管策略和商业规划有机结合。那些积极主动地合格稳健的材料供应链、透过自动化和检测实现生产现代化，并儘早与监管机构沟通的企业，将更有利于将这些优势转化为持续的临床和商业性成功。随着产业的成熟，与树脂供应商、纤维製造商、加工商、原始设备製造商 (OEM) 和临床合作伙伴等整个价值链的协作，对于扩大规模和管理风险至关重要。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 生物可吸收复合支架在整形外科手术中用于骨再生
  • 将抗菌银离子聚合物复合材料整合到医疗植入设计中
  • 开发用于义肢的高性能碳纤维增强热塑性塑料
  • 诊断成像应用中对渗透性材料的需求激增
  • 用于标靶药物递送系统的奈米复合水凝胶基质的研究进展
  • 加速石墨烯基生物感测器在医疗诊断领域商业化的监管途径

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依最终用途产业分類的医用复合材料市场

  • 航太与国防
    • 机身部件
    • 内部零件
    • 机翼部件
  • 车
    • 车身面板
    • 底盘组件
    • 内部零件
  • 卫生保健
    • 医疗设备
    • 整形外科植入
    • 义肢
  • 海洋
    • 甲板结构
    • 船体
  • 运动与休閒
    • 自行车
    • 高尔夫球桿
    • 球拍
  • 风力发电
    • 刀刃
    • 中心
    • 短舱

第九章 依树脂类型分類的医用复合材料市场

  • 热塑性塑料
    • PEEK
      • 碳纤维增强
      • 未掺假的
    • PP
      • 共聚物
      • 均聚物
    • PPS
      • 玻璃污染
      • 未掺假的
  • 热固性
    • 环氧树脂
      • 双酚A
      • 脂环族
      • 诺沃拉克
    • 聚酯纤维
      • DCPD
      • 间苯二甲酸
      • 邻苯二甲酸
    • 乙烯基酯
      • Atlac
      • Derakane
      • Veova

第十章 依纤维类型分類的医用复合材料市场

  • 酰胺纤维
    • 间位芳香聚酰胺
    • 对位芳香聚酰胺
  • 碳纤维
    • 基于PAN的
    • 基于音高的
    • 人造丝基料
  • 玻璃纤维
    • C-玻璃
    • E玻璃
    • S-玻璃

第十一章 依製造流程分類的医用复合材料市场

  • 高压釜成型
  • 压缩成型
  • 缠绕成型
  • 手工积层
  • 拉挤成型
  • 树脂转注成形

第十二章：以外形规格的医用复合材料市场

  • 管道和管材
  • 个人资料及更多
    • 材料
    • 不织布垫
  • 桿和条
  • 板材和薄板

第十三章 依产品类型分類的医用复合材料市场

  • 块状模塑胶
    • 导电块状模塑胶
    • 标准块状模塑胶
  • 丝状缠绕产品
    • 管道和管材
    • 压力容器
  • 预浸料
    • 碳预浸料
    • 玻璃预浸料
  • 拉挤型材
    • 角度
    • 频道
    • 工字钢
  • 片状成型塑料
    • 豪华SMC
    • 标准SMC

第十四章 区域性医用复合材料市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 医疗复合材料市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国医用复合材料市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Solvay SA
    • Evonik Industries AG
    • Teijin Limited
    • Victrex plc
    • Celanese Corporation
    • Koninklijke DSM NV
    • Saudi Basic Industries Corporation
    • Arkema SA
    • DuPont de Nemours, Inc.
    • 3M Company
Product Code: MRR-FD3F12D52D24

The Medical Composites Market is projected to grow by USD 5.73 billion at a CAGR of 16.99% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.63 billion
Estimated Year [2025] USD 1.91 billion
Forecast Year [2032] USD 5.73 billion
CAGR (%) 16.99%

A clear and authoritative introduction explaining how composite materials are reshaping medical device design, manufacturing, and clinical performance across care environments

Advanced composite materials have emerged as a pivotal enabler of next-generation medical devices and implants, combining mechanical performance, lightweight design, and compatibility with clinical workflows. Over the past decade, composites have migrated from niche applications into mainstream product architectures due to improvements in polymer chemistry, fiber technology, and process repeatability that together address longstanding clinical and manufacturing constraints. The convergence of biocompatible thermoplastics, tailored fiber reinforcements, and precision manufacturing has expanded design freedom for device engineers while responding to clinician demands for sterilizable, radiolucent, and fatigue-resistant components.

Clinical adoption is further supported by procedural shifts toward minimally invasive techniques and implant designs that require high strength-to-weight ratios and modularity. In parallel, healthcare procurement and hospital technology assessment groups are increasingly evaluating lifecycle performance and serviceability, elevating the importance of durable composite solutions. These dynamics compel device manufacturers, materials suppliers, and contract manufacturers to coordinate closely on material selection, process validation, and regulatory documentation. Consequently, medical composites are not merely a materials choice but a systems-level decision that influences manufacturing footprints, supply chain architecture, and the speed with which new devices can be introduced into highly regulated markets.

An incisive overview of the major technological, regulatory, and sustainability shifts that are accelerating innovation and altering competitive dynamics in medical composites

The landscape for medical composites is in the midst of transformative shifts driven by technological progress, regulatory evolution, and cross-sector knowledge transfer. Innovations in resin chemistry and fiber engineering are enabling combinations of stiffness, toughness, and sterilization compatibility previously unattainable, while additive manufacturing and automated lay-up systems are reducing labor variability and enabling patient-specific geometries. At the same time, greater emphasis on sustainability and circularity is prompting development of recyclable thermoplastics and novel resin chemistries that reduce environmental impact without compromising biocompatibility. These parallel technical and environmental trends are creating a new competitive axis for suppliers and OEMs.

Regulatory frameworks are also evolving to accommodate complex, multi-material devices. Regulators are increasingly focused on material traceability, sterilization validation, and long-term performance data, which in turn affects qualification timelines and documentation requirements. Moreover, lessons learned from aerospace and automotive sectors-especially in quality systems, nondestructive testing, and supply chain audits-are being adapted to medical contexts, accelerating maturity in manufacturing and certification practices. Together, these shifts are redefining how product roadmaps are constructed, which partnerships are prioritized, and how capital is deployed to scale manufacturing while maintaining compliance and patient safety.

A practical analysis of how 2025 tariff measures have reshaped sourcing strategies, supplier relationships, and manufacturing priorities across the medical composites value chain

The introduction of new tariff measures in the United States in 2025 has exerted a broad and cumulative influence across the medical composites ecosystem, prompting supply chain realignments and strategic responses from manufacturers and suppliers. Faced with higher import duties on certain raw materials and finished components, many organizations have reassessed sourcing strategies to reduce exposure to single-country dependencies. This has accelerated interest in supplier diversification, regional supply bases, and long-term procurement agreements that incorporate contingency provisions and cost-sharing mechanisms.

At a product level, tariffs have increased the relative attractiveness of domestically produced resins and fibers, incentivizing investments in local compounding, fiber conversion, and prepreg production. Procurement teams within medical device companies have become more proactive in qualifying alternative materials and negotiating lead times to smooth production continuity. In parallel, contract manufacturers and converters have sought to mitigate margin pressure through process optimization, yield improvement, and selective price adjustments, while also engaging in design reviews to identify opportunities for material substitution where clinically appropriate.

Policy-driven cost pressures have also spurred nearshoring conversations, with stakeholders weighing the trade-offs between labor cost, regulatory proximity, and supply reliability. Importantly, tariffs have acted as a catalyst for upstream partnerships between resin producers and device OEMs, accelerating joint development of resin grades that reduce dependence on tariff-affected inputs. Together, these responses are shifting capital allocation toward flexibility and resilience, even as organizations seek to preserve product performance and compliance.

Comprehensive segmentation insights that reveal how end use, resin chemistries, fiber classes, manufacturing routes, form factors, and product types interact to shape strategic priorities

Segment-level dynamics underscore the heterogeneity of opportunities and challenges across end uses, material types, fiber architectures, manufacturing processes, form factors, and product categories. When considering end use industry segmentation, applications span Aerospace & Defense with fuselage, interior, and wing components; Automotive with body panel, chassis, and interior components; Healthcare with medical devices, orthopedic implants, and prosthetics; Marine with deck structures and hulls; Sports & Leisure with bicycles, golf clubs, and rackets; and Wind Energy with blades, hubs, and nacelles. Each application imposes different performance, sterilization, and longevity requirements that influence material selection and qualification pathways.

Resin type segmentation further illuminates development trajectories. Thermoplastic classes, including PEEK, PP, and PPS, are gaining traction for their reprocessability and sterilization profiles; within PEEK the distinction between carbon fiber reinforced and unfilled grades affects stiffness and radiolucency, while PP copolymer and homopolymer grades balance cost and ductility and PPS glass-filled options deliver temperature and chemical resistance. Thermoset families such as epoxy, polyester, and vinyl ester remain important where high-temperature cure and specific mechanical properties are required; epoxy variants like Bisphenol-A, cycloaliphatic, and novolac offer different trade-offs in toughness and thermal stability, while polyester grades including DCPD, isophthalic, and orthophthalic serve cost-sensitive structural roles, and vinyl ester chemistries such as Atlac, Derakane, and Veova provide corrosion resistance.

Fiber type segmentation informs mechanical design and cost dynamics, with aramid fibers split into meta-aramid and para-aramid options for impact resistance and cut resistance, carbon fiber classes of PAN-based, pitch-based, and rayon-based providing varying stiffness and weight characteristics, and glass fiber types like C-Glass, E-Glass, and S-Glass offering scalable strength at competitive cost. Manufacturing process segmentation across autoclave molding, compression molding, filament winding, hand lay-up, pultrusion, and resin transfer molding introduces distinct constraints on part geometry, cycle time, and quality assurance protocols that influence unit economics and qualification timelines. Form factor considerations include pipes and tubes, profiles and others that encompass fabrics and nonwoven mats, rods and bars, and sheets and plates, each dictating downstream processing and finishing steps. Product type segmentation spans bulk molding compound in conductive and standard variants, filament wound products comprising pipes and tubes and pressure vessels, prepregs divided into carbon and glass types, pultruded profiles such as angles, channels, and I-beams, and sheet molding compound in premium and standard tiers.

Taken together, these layered segments create a matrix of technical requirements, supply risks, and commercial opportunities. Transitioning from one segment to another often requires adjustments in supplier qualification, validation protocols, and manufacturing controls. For example, a shift from hand lay-up to automated filament winding will necessitate investments in tooling, nondestructive inspection, and process monitoring. Similarly, moving from thermoset prepreg to thermoplastic solutions can unlock recycling benefits but requires retooling and requalification for sterilization compatibility. Understanding these interdependencies enables product teams to make deliberate trade-offs between performance, cost, and time to market.

A strategic regional analysis outlining how the Americas, Europe Middle East & Africa, and Asia-Pacific each influence sourcing, regulation, and manufacturing choices for medical composites

Regional dynamics play a decisive role in shaping sourcing decisions, regulatory pathways, and innovation priorities. In the Americas, the combination of established medical device clusters, proximity to major healthcare purchasers, and a regulatory environment oriented toward evidentiary rigor creates fertile ground for high-performance composite applications that demand rapid clinical adoption and close supplier collaboration. Domestic manufacturing capabilities and engineering talent pools support nearshoring strategies, which have gained momentum as organizations seek to reduce exposure to global trade volatility.

Europe, Middle East & Africa features a diverse industrial base and a regulatory landscape that emphasizes device lifecycle surveillance and traceability. The EU medical device regulatory framework and regional standards influence material qualification and post-market obligations, prompting manufacturers to invest in more comprehensive testing and documentation. Additionally, strong aerospace and wind energy clusters in parts of Europe encourage cross-pollination of advanced composite manufacturing techniques, while regional sustainability targets drive demand for recyclable and lower-emission production approaches.

Asia-Pacific offers scale and cost-competitive manufacturing capacity across several jurisdictions, with significant investments in fiber and resin production as well as composite conversion. Rapidly growing healthcare demand in parts of the region is increasing local adoption of advanced devices, and government incentives in manufacturing and technology development are accelerating capacity expansion. However, variability in regulatory maturity and supply chain transparency requires buyers to adopt rigorous qualification practices when sourcing from multiple countries within the region. Collectively, these regional attributes influence strategic decisions around supplier selection, inventory strategies, and investment in localized capabilities.

An evidence-driven assessment of how firms across resin production, fiber supply, conversion, OEMs, and service providers are differentiating through technology, integration, and regulatory capabilities

Leading organizations in the medical composites value chain are differentiating through a combination of technical excellence, supply chain integration, and regulatory expertise. Companies that focus on specialty resin development are investing in grades that balance biocompatibility, sterilization tolerance, and processability, while fiber producers are expanding capacities for carbon and glass variants that meet stringent medical performance requirements. Composite converters and contract manufacturers are scaling automation and inspection capabilities to reduce variability and raise throughput for high-mix medical programs.

Medical device OEMs are increasingly forming strategic alliances with materials suppliers to accelerate product-specific qualification and to de-risk long lead-time inputs. This trend is accompanied by deeper investment in in-house regulatory affairs and materials science teams, enabling faster translation from materials selection to clinical validation. Service providers, including testing laboratories and sterilization specialists, are expanding offerings to include accelerated aging, biocompatibility studies, and comprehensive nondestructive testing suites tailored to composite architectures.

Additionally, successful companies are prioritizing sustainability initiatives such as lifecycle assessments and recyclable material systems, recognizing that healthcare procurement officers are placing greater emphasis on environmental impact. M&A and joint development agreements are being leveraged to acquire niche capabilities, secure local supply, or access regulatory documentation, while operational leaders are investing in workforce development to bridge the skills gap in composite-specific manufacturing and quality assurance.

Actionable and practical recommendations that industry leaders can implement to enhance supply chain resilience, accelerate material qualification, and modernize manufacturing operations

Industry leaders should pursue a coordinated set of tactical and strategic actions that strengthen resilience while preserving innovation velocity. First, prioritize supply chain diversification by qualifying multiple suppliers across different regions and by establishing contingency inventory buffers for critical resins and fibers. Simultaneously, accelerate material qualification programs that validate alternative resin and fiber combinations capable of meeting clinical and sterilization requirements, thereby reducing dependency on tariff-exposed inputs.

Second, invest in manufacturing modernization to lower unit variability and improve yield, focusing on automation, inline inspection, and digital traceability. These investments shorten qualification cycles and improve reproducibility across production sites. Third, embed regulatory strategy early in product development, engaging with regulatory authorities through pre-submission consultations and maintaining robust material and process documentation to smooth approval pathways. Fourth, develop circularity strategies that include recyclable thermoplastics, design for disassembly, and validated sterilization-compatible reuse where clinically appropriate, aligning product portfolios with procurement and sustainability priorities.

Fifth, pursue collaborative models with material suppliers, contract manufacturers, and clinical partners to share risk and accelerate time to clinical adoption, while exploring co-investment in local production facilities where nearshoring delivers strategic value. Finally, invest in workforce skills and change management to ensure teams can operate new manufacturing technologies and maintain compliance, thereby translating technical investments into reliable production and market access.

A transparent methodological statement describing the integrated primary and secondary research approach, supply chain mapping, and validation steps used to derive strategic insights

The research underpinning this summary was developed using a mixed-methods approach that integrates primary stakeholder engagement, technical literature review, and targeted supply chain analysis. Primary inputs included structured interviews with materials scientists, manufacturing engineers, procurement leaders, regulatory affairs specialists, and clinical end users to capture operational constraints, performance priorities, and qualification hurdles. These interviews were complemented by reviews of peer-reviewed engineering literature, regulatory guidance documents, patent filings, and standards that inform material and process expectations in medical applications.

Supply chain mapping exercises identified key nodes for raw material conversion, prepreg and composite fabrication, and final assembly, enabling analysis of lead-time vulnerabilities and concentration risks. Technology assessments evaluated the readiness levels of thermoplastic and thermoset systems, fiber classes, and automated manufacturing platforms, while case studies highlighted successful qualification and manufacturing scale-up pathways. Findings were iteratively validated through expert workshops and cross-functional review to ensure practical applicability. Methodological limitations include variability in proprietary qualification standards across organizations and evolving policy environments; where appropriate, conservative language was used to reflect areas of uncertainty.

A concise conclusion that synthesizes how material innovation, manufacturing modernization, and strategic supply chain decisions will determine success in medical composites

Medical composites are at an inflection point where material innovation, manufacturing evolution, and policy dynamics converge to create both risk and opportunity. The sector's ability to deliver lighter, stronger, and clinically compatible solutions is expanding the universe of possible device designs, while regulatory and procurement expectations demand higher levels of traceability and performance documentation. Trade policy shifts and regional dynamics are accelerating strategic realignment of supply chains, prompting investments in diversification, nearshoring, and supplier partnerships.

To navigate this environment, organizations must adopt an integrated approach that aligns materials science, process engineering, regulatory strategy, and commercial planning. Companies that proactively qualify resilient material supply chains, modernize manufacturing with automation and inspection, and engage regulators early will be best positioned to translate composite advantages into durable clinical and commercial success. Collaboration across the value chain-between resin suppliers, fiber producers, converters, OEMs, and clinical partners-will be essential to unlock scale and manage risk as the industry matures.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of bioabsorbable composite scaffolds for bone regeneration in orthopedic surgery
  • 5.2. Integration of antimicrobial silver-infused polymer composites in medical implant design
  • 5.3. Development of high-performance carbon fiber reinforced thermoplastics for prosthetic limbs
  • 5.4. Surge in demand for radiolucent composite materials in diagnostic imaging applications
  • 5.5. Advancements in nanocomposite hydrogel matrices for targeted drug delivery systems
  • 5.6. Regulatory pathways accelerating commercialization of graphene-based biosensors in medical diagnostics

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Composites Market, by End Use Industry

  • 8.1. Aerospace & Defense
    • 8.1.1. Fuselage Components
    • 8.1.2. Interior Components
    • 8.1.3. Wing Components
  • 8.2. Automotive
    • 8.2.1. Body Panel
    • 8.2.2. Chassis Components
    • 8.2.3. Interior Components
  • 8.3. Healthcare
    • 8.3.1. Medical Devices
    • 8.3.2. Orthopedic Implants
    • 8.3.3. Prosthetics
  • 8.4. Marine
    • 8.4.1. Deck Structures
    • 8.4.2. Hulls
  • 8.5. Sports & Leisure
    • 8.5.1. Bicycles
    • 8.5.2. Golf Clubs
    • 8.5.3. Rackets
  • 8.6. Wind Energy
    • 8.6.1. Blades
    • 8.6.2. Hubs
    • 8.6.3. Nacelles

9. Medical Composites Market, by Resin Type

  • 9.1. Thermoplastic
    • 9.1.1. PEEK
      • 9.1.1.1. Carbon Fiber Reinforced
      • 9.1.1.2. Unfilled
    • 9.1.2. PP
      • 9.1.2.1. Copolymer
      • 9.1.2.2. Homopolymer
    • 9.1.3. PPS
      • 9.1.3.1. Glass Filled
      • 9.1.3.2. Unfilled
  • 9.2. Thermoset
    • 9.2.1. Epoxy
      • 9.2.1.1. Bisphenol-A
      • 9.2.1.2. Cycloaliphatic
      • 9.2.1.3. Novolac
    • 9.2.2. Polyester
      • 9.2.2.1. DCPD
      • 9.2.2.2. Isophthalic
      • 9.2.2.3. Orthophthalic
    • 9.2.3. Vinyl Ester
      • 9.2.3.1. Atlac
      • 9.2.3.2. Derakane
      • 9.2.3.3. Veova

10. Medical Composites Market, by Fiber Type

  • 10.1. Aramid Fiber
    • 10.1.1. Meta-Aramid
    • 10.1.2. Para-Aramid
  • 10.2. Carbon Fiber
    • 10.2.1. PAN-Based
    • 10.2.2. Pitch-Based
    • 10.2.3. Rayon-Based
  • 10.3. Glass Fiber
    • 10.3.1. C-Glass
    • 10.3.2. E-Glass
    • 10.3.3. S-Glass

11. Medical Composites Market, by Manufacturing Process

  • 11.1. Autoclave Molding
  • 11.2. Compression Molding
  • 11.3. Filament Winding
  • 11.4. Hand Lay-Up
  • 11.5. Pultrusion
  • 11.6. Resin Transfer Molding

12. Medical Composites Market, by Form Factor

  • 12.1. Pipes & Tubes
  • 12.2. Profiles & Others
    • 12.2.1. Fabrics
    • 12.2.2. Nonwoven Mats
  • 12.3. Rods & Bars
  • 12.4. Sheets & Plates

13. Medical Composites Market, by Product Type

  • 13.1. Bulk Molding Compound
    • 13.1.1. Conductive BMC
    • 13.1.2. Standard BMC
  • 13.2. Filament Wound Products
    • 13.2.1. Pipes & Tubes
    • 13.2.2. Pressure Vessels
  • 13.3. Prepreg
    • 13.3.1. Carbon Prepreg
    • 13.3.2. Glass Prepreg
  • 13.4. Pultruded Profiles
    • 13.4.1. Angles
    • 13.4.2. Channels
    • 13.4.3. I-Beams
  • 13.5. Sheet Molding Compound
    • 13.5.1. Premium SMC
    • 13.5.2. Standard SMC

14. Medical Composites Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Medical Composites Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Medical Composites Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Solvay SA
    • 17.3.2. Evonik Industries AG
    • 17.3.3. Teijin Limited
    • 17.3.4. Victrex plc
    • 17.3.5. Celanese Corporation
    • 17.3.6. Koninklijke DSM N.V.
    • 17.3.7. Saudi Basic Industries Corporation
    • 17.3.8. Arkema S.A.
    • 17.3.9. DuPont de Nemours, Inc.
    • 17.3.10. 3M Company

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL COMPOSITES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY END USE INDUSTRY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY END USE INDUSTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RESIN TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RESIN TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FIBER TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FIBER TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FORM FACTOR, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FORM FACTOR, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA MEDICAL COMPOSITES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MEDICAL COMPOSITES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE MEDICAL COMPOSITES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST MEDICAL COMPOSITES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA MEDICAL COMPOSITES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC MEDICAL COMPOSITES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN MEDICAL COMPOSITES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC MEDICAL COMPOSITES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION MEDICAL COMPOSITES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS MEDICAL COMPOSITES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 MEDICAL COMPOSITES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO MEDICAL COMPOSITES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. MEDICAL COMPOSITES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. MEDICAL COMPOSITES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MEDICAL COMPOSITES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MEDICAL COMPOSITES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL COMPOSITES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AEROSPACE & DEFENSE, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AEROSPACE & DEFENSE, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AEROSPACE & DEFENSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AEROSPACE & DEFENSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AEROSPACE & DEFENSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AEROSPACE & DEFENSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AEROSPACE & DEFENSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AEROSPACE & DEFENSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FUSELAGE COMPONENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FUSELAGE COMPONENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FUSELAGE COMPONENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FUSELAGE COMPONENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FUSELAGE COMPONENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FUSELAGE COMPONENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY INTERIOR COMPONENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY INTERIOR COMPONENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY INTERIOR COMPONENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY INTERIOR COMPONENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY INTERIOR COMPONENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY INTERIOR COMPONENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WING COMPONENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WING COMPONENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WING COMPONENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WING COMPONENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WING COMPONENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WING COMPONENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AUTOMOTIVE, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AUTOMOTIVE, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AUTOMOTIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AUTOMOTIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AUTOMOTIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AUTOMOTIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AUTOMOTIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AUTOMOTIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BODY PANEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BODY PANEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BODY PANEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BODY PANEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BODY PANEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BODY PANEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CHASSIS COMPONENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CHASSIS COMPONENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CHASSIS COMPONENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CHASSIS COMPONENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CHASSIS COMPONENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CHASSIS COMPONENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY INTERIOR COMPONENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY INTERIOR COMPONENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY INTERIOR COMPONENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY INTERIOR COMPONENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY INTERIOR COMPONENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY INTERIOR COMPONENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HEALTHCARE, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HEALTHCARE, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MEDICAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MEDICAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PROSTHETICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PROSTHETICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PROSTHETICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PROSTHETICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PROSTHETICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PROSTHETICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MARINE, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MARINE, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MARINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MARINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MARINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MARINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MARINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MARINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DECK STRUCTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DECK STRUCTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DECK STRUCTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DECK STRUCTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DECK STRUCTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DECK STRUCTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HULLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HULLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HULLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HULLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HULLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HULLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY SPORTS & LEISURE, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY SPORTS & LEISURE, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY SPORTS & LEISURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY SPORTS & LEISURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY SPORTS & LEISURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY SPORTS & LEISURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY SPORTS & LEISURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY SPORTS & LEISURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BICYCLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BICYCLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BICYCLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BICYCLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BICYCLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BICYCLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GOLF CLUBS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GOLF CLUBS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GOLF CLUBS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GOLF CLUBS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GOLF CLUBS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GOLF CLUBS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RACKETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RACKETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RACKETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RACKETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RACKETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RACKETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WIND ENERGY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WIND ENERGY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WIND ENERGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WIND ENERGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WIND ENERGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WIND ENERGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WIND ENERGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WIND ENERGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BLADES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BLADES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BLADES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BLADES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BLADES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BLADES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HUBS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HUBS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HUBS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HUBS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HUBS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HUBS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY NACELLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY NACELLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY NACELLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY NACELLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY NACELLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY NACELLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RESIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RESIN TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOPLASTIC, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOPLASTIC, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOPLASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOPLASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOPLASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOPLASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOPLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOPLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PEEK, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PEEK, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PEEK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PEEK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PEEK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PEEK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PEEK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PEEK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CARBON FIBER REINFORCED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CARBON FIBER REINFORCED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CARBON FIBER REINFORCED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CARBON FIBER REINFORCED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CARBON FIBER REINFORCED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CARBON FIBER REINFORCED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY UNFILLED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY UNFILLED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY UNFILLED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY UNFILLED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY UNFILLED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY UNFILLED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY COPOLYMER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY COPOLYMER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY COPOLYMER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY COPOLYMER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY COPOLYMER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY COPOLYMER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HOMOPOLYMER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HOMOPOLYMER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HOMOPOLYMER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HOMOPOLYMER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HOMOPOLYMER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HOMOPOLYMER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PPS, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PPS, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GLASS FILLED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GLASS FILLED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GLASS FILLED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GLASS FILLED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GLASS FILLED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GLASS FILLED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY UNFILLED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY UNFILLED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY UNFILLED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY UNFILLED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY UNFILLED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY UNFILLED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOSET, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOSET, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOSET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOSET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOSET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOSET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOSET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOSET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY EPOXY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY EPOXY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY EPOXY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY EPOXY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY EPOXY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY EPOXY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY EPOXY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY EPOXY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BISPHENOL-A, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BISPHENOL-A, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BISPHENOL-A, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BISPHENOL-A, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BISPHENOL-A, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BISPHENOL-A, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CYCLOALIPHATIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CYCLOALIPHATIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CYCLOALIPHATIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CYCLOALIPHATIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CYCLOALIPHATIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CYCLOALIPHATIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY NOVOLAC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY NOVOLAC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY NOVOLAC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY NOVOLAC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY NOVOLAC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY NOVOLAC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY POLYESTER, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY POLYESTER, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY POLYESTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY POLYESTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY POLYESTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY POLYESTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DCPD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DCPD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DCPD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DCPD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DCPD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DCPD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ISOPHTHALIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ISOPHTHALIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ISOPHTHALIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ISOPHTHALIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ISOPHTHALIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ISOPHTHALIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ORTHOPHTHALIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ORTHOPHTHALIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ORTHOPHTHALIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ORTHOPHTHALIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ORTHOPHTHALIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ORTHOPHTHALIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VINYL ESTER, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VINYL ESTER, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VINYL ESTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VINYL ESTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VINYL ESTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VINYL ESTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VINYL ESTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VINYL ESTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ATLAC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ATLAC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ATLAC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ATLAC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ATLAC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ATLAC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DERAKANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DERAKANE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DERAKANE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DERAKANE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DERAKANE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DERAKANE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VEOVA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 308. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VEOVA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 309. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VEOVA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 310. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VEOVA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VEOVA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VEOVA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FIBER TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FIBER TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ARAMID FIBER, 2018-2024 (USD MILLION)
  • TABLE 316. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ARAMID FIBER, 2025-2032 (USD MILLION)
  • TABLE 317. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ARAMID FIBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 318. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ARAMID FIBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 319. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ARAMID FIBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 320. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ARAMID FIBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 321. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ARAMID FIBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 322. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ARAMID FIBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 323. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY META-ARAMID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 324. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY META-ARAMID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 325. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY META-ARAMID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 326. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY META-ARAMID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 327. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY META-ARAMID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 328. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY META-ARAMID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 329. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PARA-ARAMID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 330. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PARA-ARAMID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 331. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PARA-ARAMID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 332. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PARA-ARAMID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 333. GLOBAL MEDICAL COMPOSITES MARK